Recent studies confirm that precision tools like OCT and AI-guided procedures are not only safer but also more effective in ...

Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk.

The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse ...

"Most PCIs are done on patients admitted with unstable coronary syndromes, so cardiologists perform the majority of PCIs ...

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

Background: Differences exist between European and American guideline recommendations regarding targets for low-density ...

The ACCELERATION study (Adenosine Contrast Correlations in Evaluating Revascularization ... Future data evaluating the impact on clinical outcomes of cFFR-guided percutaneous coronary intervention are ...

The authors sought to evaluate outcomes related to bleeding, spontaneous myocardial infarction (MI), repeat revascularization, cancer recurrence, and all‐cause death. These outcomes were compared in 2 ...

Background: Upper gastrointestinal bleeding (UGIB) is a common complication in patients with non-ST-segment elevation myocardial infarction (NSTEMI) after percutaneous coronary intervention (PCI), and ...